NYSE
CLVT

CLARIVATE PLC

Information Technology Services
Technology

Prices are adjusted according to historical splits.

CLARIVATE PLC Stock Price

Vitals

Today's Low:
$7.07
Today's High:
$7.235
Open Price:
$7.11
52W Low:
$7.155
52W High:
$15.105
Prev. Close:
$7.07
Volume:
2885470

Company Statistics

Market Cap.:
$5.41 billion
Book Value:
8.24
Revenue TTM:
$2.63 billion
Operating Margin TTM:
10.1%
Gross Profit TTM:
$1.71 billion
Profit Margin:
-151.76%
Return on Assets TTM:
0.99%
Return on Equity TTM:
-42.7%

Company Profile

CLARIVATE PLC had its IPO on 2018-10-29 under the ticker symbol CLVT.

The company operates in the Technology sector and Information Technology Services industry. CLARIVATE PLC has a staff strength of 11,600 employees.

Stock update

Shares of CLARIVATE PLC opened at $7.11 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $7.07 - $7.24, and closed at $7.12.

This is a +0.71% increase from the previous day's closing price.

A total volume of 2,885,470 shares were traded at the close of the day’s session.

In the last one week, shares of CLARIVATE PLC have slipped by -2.33%.

CLARIVATE PLC's Key Ratios

CLARIVATE PLC has a market cap of $5.41 billion, indicating a price to book ratio of 1.3003 and a price to sales ratio of 2.3257.

In the last 12-months CLARIVATE PLC’s revenue was $2.63 billion with a gross profit of $1.71 billion and an EBITDA of $972 million. The EBITDA ratio measures CLARIVATE PLC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, CLARIVATE PLC’s operating margin was 10.1% while its return on assets stood at 0.99% with a return of equity of -42.7%.

In Q1, CLARIVATE PLC’s quarterly earnings growth was a positive 0% while revenue growth was a negative 5%.

CLARIVATE PLC’s PE and PEG Ratio

Forward PE
11.7233
Trailing PE
0
PEG
6.16

Its diluted EPS in the last 12-months stands at $-6.31 per share while it has a forward price to earnings multiple of 11.7233 and a PEG multiple of 6.16. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CLARIVATE PLC’s profitability.

CLARIVATE PLC stock is trading at a EV to sales ratio of 4.9556 and a EV to EBITDA ratio of -3.7378. Its price to sales ratio in the trailing 12-months stood at 2.3257.

CLARIVATE PLC stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$13.94 billion
Total Liabilities
$1.61 billion
Operating Cash Flow
$-60400000.00
Capital Expenditure
$59.30 million
Dividend Payout Ratio
0%

CLARIVATE PLC ended 2024 with $13.94 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $13.94 billion while shareholder equity stood at $6.96 billion.

CLARIVATE PLC ended 2024 with $313.60 million in deferred long-term liabilities, $1.61 billion in other current liabilities, 11778400000.00 in common stock, $-5634200000.00 in retained earnings and $2.89 billion in goodwill. Its cash balance stood at $364.20 million and cash and short-term investments were $364.20 million. The company’s total short-term debt was $25,700,000 while long-term debt stood at $4.88 billion.

CLARIVATE PLC’s total current assets stands at $1.45 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $838.60 million compared to accounts payable of $101.70 million and inventory worth $0.

In 2024, CLARIVATE PLC's operating cash flow was $-60400000.00 while its capital expenditure stood at $59.30 million.

Comparatively, CLARIVATE PLC paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$7.12
52-Week High
$15.105
52-Week Low
$7.155
Analyst Target Price
$12.06

CLARIVATE PLC stock is currently trading at $7.12 per share. It touched a 52-week high of $15.105 and a 52-week low of $15.105. Analysts tracking the stock have a 12-month average target price of $12.06.

Its 50-day moving average was $8.18 and 200-day moving average was $9.03 The short ratio stood at 0.01 indicating a short percent outstanding of 0%.

Around 959.2% of the company’s stock are held by insiders while 9242.2% are held by institutions.

Frequently Asked Questions About CLARIVATE PLC

The stock symbol (also called stock or share ticker) of CLARIVATE PLC is CLVT

The IPO of CLARIVATE PLC took place on 2018-10-29

Similar Industry Stocks (Information Technology Services)

Last Price
Chg
Chg%
$0.38
-0.02
-5%
$0.03
0
+13.64%
$7.01
-0.36
-4.88%
$7.3
-0.01
-0.14%
$16.09
0.25
+1.58%
$2.82
-0.29
-9.32%
$32.75
-0.14
-0.43%
$2.93
0.1
+3.53%
CRISIL Limited (CRISIL)
$3856
-69.85
-1.78%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Clarivate Plc, an information, analytics, and workflow company, provides structured information and analytics for discovery, development, protection, commercialization, and measurement of scientific research, innovations, and brands. The company operates through three segments: Academia and Government, Life Sciences and Healthcare, and Intellectual Property. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ProQuest One, Pivot, Polaris, eBook Central, Vegs, Alma, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis products for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs; and Real World Data, Dialog, Drug Safety Triager, and healthcare and data solutions. The company also provides Derwent products, which include Derwent Innovation, Innography, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; and CompuMark products, such as trademark screening, searching, and watching products and services. It serves government and academic institutions, and life science and healthcare companies in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Address

70 St. Mary Axe, London, United Kingdom, EC3A 8BE